Demo Contact

Is There a Compliance Blind Spot in Your Study?

Oversight is a sponsor responsibility that can't be delegated. Integral to good Oversight is ensuring that sites and other stakeholders are compliant with multiple aspects of study conduct. Metrics exist for items like CRF completion but most studies have compliance blind spots on documentation, communication and engagement.

The myClin Compliance Score solves this by giving you an objective, inspection ready tool to track:
  • Readership of essential study documents
  • Delivery of critical study updates
  • Stakeholder training & study communication

Compliance Illustration

Compliance Scoring

  • By tracking user interactions with study content, such as views, prints and acknowledgements myClin generates a compliance score at the study, site or staff member level.
  • This indicates how compliant that entity is with engaging with the study information they need to be aware of.
  • The score quickly guides the viewer to less compliant areas of a study - so helping with risk management interventions.

Ready to review and improve your compliance?

Identify gaps and blind spots in your study compliance today with our Compliance Risk Estimator.

It only takes minutes to respond to assessment questions and receive a free ranking with actionable recommendations.

Get Started Now

Continuous & Contemporaneous Oversight

  • Automatically document your Oversight steps throughout your study.
  • Record evidence of good study execution on a contemporaneous basis.
  • Stay inspection ready at all times.

 

"myClin makes it simple to centralize and disseminate essential information across our clinical study team." - Vice President, Clinical Operations, Trevena
trevena

Watch Customer Story Webinar

Efficient Collaboration

  • Find the right documentation to follow at any time
  • Bring new team members on board faster
  • Reduce physical paper files at clinical sites and across the study
  • Maintain a high level of site engagement

 

"At any time, we can know who in the team has received an essential piece of information or training." - Head of Clinical Development & Operations, Inivata

Inivita

Clinical Oversight Platform

  • Sponsors and CROs are repeatedly receiving adverse inspection findings about inadequate Oversight.
  • myClin is the only tool structured specifically to capture your Oversight steps automatically and throughout your study.
  • Rely on this ICH E6 R2 supporting and 21CFR11 compliant platform.

 

"myClin lets us achieve a more demonstrable compliance. We can review and present real-life data on demand." - ‎Director, Clinical Operations

 

128
Sites, Sponsors, and Service Providers
1
Countries
32
Channels from Over 100 Studies
2568
User Accounts
  • Testimonial
    myClin has developed a cloud-based tool to simplify communication and task management between trial sponsor, lead investigator, site manager and service providers in between.
    Stephanie BaumMedCity News
  • Testimonial
    Speaking online, managing digital relationships, writing for the web: Developing these skills in your staff is a 21st century mandate.
    James DenmarkFounder and CEO, myClin - DIA Presentation
  • Testimonial
    myClin breaks down the barriers and opens channels of communication. Everyone together in one virtual community brings all parties closer to the science.
    Suz RedfearnCenterWatch

Meet the myClin Team at Upcoming Events and Conferences.

OOCT Nordics
LPSA
OCT UK
exl events
CQR

OBN

One Nucleus

What Will It Take to Change the Game in Clinical Trials?

myClin organizes and sponsors the Clinical Innovators Summit, an international event series bringing together leading and innovative organizations in the industry. Join our next event to discuss how to simplify, unify, and advance Oversight and improve collaboration in clinical trials!

Nektar

Watch CIS West Coast Recap

Request a Personalized Demo

myClin Selected for Unprecedented Collaborative Clinical Trial by The Leukemia & Lymphoma Society (LLS)

LLS Beat AML Trial

myClin will be utilized to connect thirteen organizations in a first-ever collaborative clinical trial to treat Acute Myeloid Leukemia (AML), a form of cancer affecting 20,000 americans annually.

Watch Customer Story